Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alistair Mathie

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
The Journal of Physiology|June 23, 2010
Gating of two pore domain potassium channelsAlistair Mathie, Ehab Al-Moubarak, Emma L Veale
British Journal of Pharmacology|March 29, 2005
Guide to receptors and channels, 1st edition (2005 revision)Stephen P H Alexander, Alistair Mathie, John A Peters
British Journal of Pharmacology|November 2, 2011
Guide to Receptors and Channels (GRAC), 5th editionStephen P H Alexander, Alistair Mathie, John A Peters
Biochemistry and Biophysics Reports|May 27, 2021
Block of TREK and TRESK K2P channels by lamotrigine and two derivatives sipatrigine and CEN-092Yvonne Walsh, Michael Leach, Emma L Veale, et al.
The Journal of Biological Chemistry|July 8, 2010
Dominant negative effects of a non-conducting TREK1 splice variant expressed in brainEmma L Veale, Kathryn A Rees, Alistair Mathie, et al.
Molecular Pharmacology|August 24, 2004
The two-pore-domain K(+) channels TREK-1 and TASK-3 are differentially modulated by copper and zincMarco Gruss, Alistair Mathie, William R Lieb, et al.
Cerebellum (London, England)|July 29, 2003
What are the roles of the many different types of potassium channel expressed in cerebellar granule cells?Alistair Mathie, Catherine E Clarke, Kishani M Ranatunga, et al.
Frontiers in Pharmacology|July 16, 2021
The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium ChannelsKevin P Cunningham, Lucie H Clapp, Alistair Mathie, et al.
Pharmacology & Therapeutics|January 18, 2006
Zinc and copper: pharmacological probes and endogenous modulators of neuronal excitabilityAlistair Mathie, Gemma L Sutton, Catherine E Clarke, et al.
Acta Physiologica (Oxford, England)|August 20, 2019
Effects of the ventilatory stimulant, doxapram on human TASK-3 (KCNK9, K2P9.1) channels and TASK-1 (KCNK3, K2P3.1) channelsKevin P Cunningham, D Euan MacIntyre, Alistair Mathie, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
The Journal of Physiology|June 23, 2010
Gating of two pore domain potassium channelsAlistair Mathie, Ehab Al-Moubarak, Emma L Veale
British Journal of Pharmacology|March 29, 2005
Guide to receptors and channels, 1st edition (2005 revision)Stephen P H Alexander, Alistair Mathie, John A Peters
British Journal of Pharmacology|November 2, 2011
Guide to Receptors and Channels (GRAC), 5th editionStephen P H Alexander, Alistair Mathie, John A Peters
Biochemistry and Biophysics Reports|May 27, 2021
Block of TREK and TRESK K2P channels by lamotrigine and two derivatives sipatrigine and CEN-092Yvonne Walsh, Michael Leach, Emma L Veale, et al.
The Journal of Biological Chemistry|July 8, 2010
Dominant negative effects of a non-conducting TREK1 splice variant expressed in brainEmma L Veale, Kathryn A Rees, Alistair Mathie, et al.
Molecular Pharmacology|August 24, 2004
The two-pore-domain K(+) channels TREK-1 and TASK-3 are differentially modulated by copper and zincMarco Gruss, Alistair Mathie, William R Lieb, et al.
Cerebellum (London, England)|July 29, 2003
What are the roles of the many different types of potassium channel expressed in cerebellar granule cells?Alistair Mathie, Catherine E Clarke, Kishani M Ranatunga, et al.
Frontiers in Pharmacology|July 16, 2021
The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium ChannelsKevin P Cunningham, Lucie H Clapp, Alistair Mathie, et al.
Pharmacology & Therapeutics|January 18, 2006
Zinc and copper: pharmacological probes and endogenous modulators of neuronal excitabilityAlistair Mathie, Gemma L Sutton, Catherine E Clarke, et al.
Acta Physiologica (Oxford, England)|August 20, 2019
Effects of the ventilatory stimulant, doxapram on human TASK-3 (KCNK9, K2P9.1) channels and TASK-1 (KCNK3, K2P3.1) channelsKevin P Cunningham, D Euan MacIntyre, Alistair Mathie, et al.
Pageof 7